We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$847M
AUM Growth
+$73.3M
Cap. Flow
+$24.4M
Cap. Flow %
2.88%
Top 10 Hldgs %
61.2%
Holding
102
New
12
Increased
20
Reduced
2
Closed
1
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
2.1 years

Top Sells

Rank Stock Value
1
OCRX
Ocera Therapeutics, Inc.
OCRX
+$771K
2
BMY icon
Bristol-Myers Squibb
BMY
+$450K

Sector Composition

Rank Sector Weight
1 Financials 39.48%
2 Healthcare 25.06%
3 Industrials 10.63%
4 Technology 10.11%
5 Materials 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SNY icon
26
Sanofi
SNY
$96.5B
$7.37M 0.87%
171,300
– –
2014 Q1
15 quarters
BIIB icon
27
Biogen
BIIB
$34.8B
$7.24M 0.85%
22,720
– –
2015 Q4
8 quarters
XOM icon
28
ExxonMobil
XOM
$718B
$6.82M 0.8%
81,493
– –
2014 Q1
15 quarters
CSCO icon
29
Cisco
CSCO
$433B
$6.28M 0.74%
163,890
– –
2014 Q1
15 quarters
USB icon
30
US Bancorp
USB
$89.4B
$6.05M 0.71%
112,900
– –
2016 Q2
6 quarters
BBL
31
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$5.21M 0.61%
+129,200
New +$4.8M
2017 Q4
0 quarters
BDX icon
32
Becton Dickinson
BDX
$52.8B
$4.88M 0.58%
23,370
– –
2014 Q1
15 quarters
BMY icon
33
Bristol-Myers Squibb
BMY
$124B
$4.75M 0.56%
77,600
-7,200
-8% -$450K
2016 Q2
6 quarters
VOO icon
34
Vanguard S&P 500 ETF
VOO
$1.05T
$4.51M 0.53%
18,400
– –
2017 Q2
2 quarters
SGYP
35
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$4.24M 0.5%
1,900,000
+400,000
+27% +$994K
2017 Q1
3 quarters
MDT icon
36
Medtronic
MDT
$122B
$4.09M 0.48%
50,700
– –
2014 Q1
15 quarters
GOOG icon
37
Alphabet (Google) Class C
GOOG
$4.22T
$4.08M 0.48%
78,000
– –
2014 Q1
15 quarters
SRCL icon
38
DELISTED
Stericycle Inc
SRCL
$2.89M 0.34%
42,500
+6,700
+19% +$455K
2015 Q1
11 quarters
DO icon
39
DELISTED
Diamond Offshore Drilling
DO
$2.12M 0.25%
113,800
– –
2014 Q4
12 quarters
KO icon
40
Coca-Cola
KO
$396B
$2.11M 0.25%
46,000
– –
2014 Q1
15 quarters
DVAX icon
41
DELISTED
Dynavax Technologies
DVAX
$2.03M 0.24%
108,755
– –
2017 Q1
3 quarters
KHC icon
42
The Kraft Heinz Company
KHC
$27.6B
$2.02M 0.24%
26,020
+6,700
+35% +$526K
2015 Q3
9 quarters
BDSI
43
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.77M 0.21%
601,285
– –
2017 Q1
3 quarters
AXP icon
44
American Express
AXP
$212B
$1.75M 0.21%
17,600
– –
2014 Q1
15 quarters
MCD icon
45
McDonald's
MCD
$172B
$1.73M 0.2%
10,060
– –
2014 Q4
12 quarters
UTHR icon
46
United Therapeutics
UTHR
$23.2B
$1.7M 0.2%
11,490
– –
2016 Q3
5 quarters
ASHR icon
47
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.34B
$1.61M 0.19%
51,900
– –
2017 Q2
2 quarters
JKHY icon
48
Jack Henry & Associates
JKHY
$11B
$1.6M 0.19%
13,700
– –
2017 Q2
2 quarters
MA icon
49
Mastercard
MA
$540B
$1.51M 0.18%
10,000
– –
2014 Q1
15 quarters
CBI
50
DELISTED
Chicago Bridge & Iron Nv
CBI
$1.5M 0.18%
93,000
– –
2014 Q3
13 quarters

Similar funds

Hikari Power's Q4 2017 Portfolio in Review

As of Q4 2017, Hikari Power held 102 positions worth $847M, up 9.5% from $774M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Hikari Power's Q4 2017 filing shows 12 new, 20 increased, 2 reduced and 1 closed positions. Its largest new stake was BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares): 129,200 shares worth $5.21M. The largest sale was Ocera Therapeutics, Inc., an estimated $771K.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q4 2017 buy was BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares): 129,200 shares worth $5.21M.
  • Hikari Power added most to Allergan plc in Q4 2017, an estimated $3.43M increase.
  • Hikari Power's biggest Q4 2017 reduction was Bristol-Myers Squibb, cutting an estimated $450K.
  • Hikari Power fully exited Ocera Therapeutics, Inc. in Q4 2017, selling an estimated $771K.
  • Hikari Power's ten largest holdings make up 61% of its $847M portfolio in Q4 2017.
  • Hikari Power opened 12 new positions and closed 1 in Q4 2017.
  • Hikari Power's portfolio value rose 9.5% quarter-over-quarter to $847M.

Based on Hikari Power's 13F filing for Q4 2017, filed 12 Jan 2018.